Terns Pharmaceuticals, Inc. (TERN) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts TERN Hot Sheet
Join SI Premium – FREE
Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q2 EPS of ($0.25), $0.08 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Aspire Biopharma to acquire automotive supplier for $30 million
- Sharon AI surges premarket; New Oriental gains, Medline slips
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
